Caris Life Sciences is one of the largest precision-oncology platforms in the world, serving hundreds of thousands of molecular cases a year and growing at double-digit rates. Behind every case is a matched molecular, imaging, and clinical-outcomes data estate few organizations anywhere can rival, and the clinical software that drives the lab’s instruments and processes, captures results, and delivers each patient’s report. When that software degrades, patient care waits; keeping it reliable is this role’s charter.
Reporting to the Corporate Vice President for Clinical Software Products, the Director owns application reliability and production operations for the clinical software portfolio: production support, incident response, on-call operations, and SLO management for applications under SOX financial controls and FDA regulatory requirements. The Director hires and develops the team, sets standards and selects tooling, establishes production-access governance and segregation-of-duties controls with the information-security, quality, and infrastructure organizations, and participates directly in incident response. The role carries wide latitude to shape how reliability engineering is done here.
Frontier AI coding assistants are standard-issue tooling, with agentic workflows spanning incident diagnostics, runbook authoring, and operational automation. Characterization tests and golden-master replay validation serve as executable evidence for regulated change. Delivery runs on CI/CD with application-level observability and risk-based release governance aligned with FDA Computer Software Assurance guidance. Modernization of established systems is active engineering work, not deferred maintenance.
The infrastructure organization owns the platform and observability runtime; this role owns application-layer reliability on top of it. The operating model is automation-first: recurring manual work is engineered away rather than staffed, and operational and compliance evidence is produced by pipelines rather than assembled by hand.
Location: Irving, Texas (Dallas–Fort Worth), on-site/hybrid, minimum three days per week on campus; co-located with Caris’s laboratory and clinical operations.